Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
4 pending office actions • 4 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (25%) |
| §103 only | 1 (25%) |
| §112 only | 1 (25%) |
| No statute on record | 1 (25%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GONZALEZ, LUISALBERTO | 1 | 59.7% | +46.8% |
| BERKELEY, EMILY R | 1 | 75.7% | +28.6% |
| YOO, SUN JAE | 1 | 71.0% | +0.3% |
| STAVROU, CONSTANTINA E | 1 | 43.7% | +36.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18300582 | THERAPEUTIC DRUG FOR LIPID-PEROXIDATION-INDUCED DISEASES AND SCREENING METHOD FOR THERAPEUTIC DRUGS FOR LIPID-PEROXIDATION-INDUCED DISEASES | BERKELEY, EMILY R | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18567284 | T-TYPE CALCIUM CHANNEL BLOCKER | GONZALEZ, LUISALBERTO | — |
| 18300582 | THERAPEUTIC DRUG FOR LIPID-PEROXIDATION-INDUCED DISEASES AND SCREENING METHOD FOR THERAPEUTIC DRUGS FOR LIPID-PEROXIDATION-INDUCED DISEASES | BERKELEY, EMILY R | — |
| 17252137 | CULTURE MEDIUM FOR ASSISTED REPRODUCTIVE TECHNOLOGY | STAVROU, CONSTANTINA E | — |
| Art Unit | Apps |
|---|---|
| 1624 | 1 |
| 1796 | 1 |
| 1621 | 1 |
| 1632 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18567284 | T-TYPE CALCIUM CHANNEL BLOCKER | GONZALEZ, LUISALBERTO | 1624 | §112 | Final Rejection | — | Pending | Dec 05, 2023 |
| 18300582 | THERAPEUTIC DRUG FOR LIPID-PEROXIDATION-INDUCED DISEASES AND SCREENING METHOD FOR THERAPEUTIC DRUGS FOR LIPID-PEROXIDATION-INDUCED DISEASES | BERKELEY, EMILY R | 1796 | §101§102§112 | Non-Final OA | — | Pending | Apr 14, 2023 |
| 17422057 | PHARMACEUTICAL COMPOSITION FOR INTRAOCULAR OR ORAL ADMINISTRATION FOR TREATMENT OF RETINAL DISEASES | YOO, SUN JAE | 1621 | — | Non-Final OA | — | Pending | Jul 09, 2021 |
| 17252137 | CULTURE MEDIUM FOR ASSISTED REPRODUCTIVE TECHNOLOGY | STAVROU, CONSTANTINA E | 1632 | §103 | Final Rejection | — | Pending | Dec 14, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial